Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: energyplay who wrote (61093)	3/17/2005 2:31:55 AM
From: Raymond Duray	Read Replies (2) \| Respond to of 74559

Re: Might be unfortunate if that lab had a small fire.... Precisely my point. Only a big fire would yield the sort of insurance settlement to make such an enterprise worthwhile. Re: I believe some of the Indian and/or South African production is part of a licsencing deal where they are restricted in where they can sell. Some of the figures are stunning. Some drugs sold in the U.S. for $200.00 per script by Big Pharma are subcontracted to generic manufacturers in India who are producing and wholesaling product for $2.00. You really have to marvel at how ignorant the American public is about how severely they are being ripped off by Big Pharma.